Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lpm.2008.10.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Artifactual hypoglycemia revealing an acrosyndrome: better believe in the glucose sensor.
Acta Diabetol
August 2024
CHU de REIMS, REIMS, France.
Artifactual hypoglycemia revealing an acrosyndrome: better believe in the glucose sensor.
Acta Diabetol
December 2024
CHU de REIMS, REIMS, France.
New and Delayed Artifactual Hypoglycemia Following Septic Shock in Two Scleroderma Patients.
Cureus
July 2023
Hospital Medicine, Olive View University of California Los Angeles Medical Center, Los Angeles, USA.
The term artifactual hypoglycemia refers to a discrepancy between plasma glucose levels and what is noted on fingerstick glucose checks. In this report, we discuss the cases of two patients with scleroderma and Raynaud's phenomenon who developed artifactual hypoglycemia while recovering from critical illness. In both cases, validation by earlobe measurements helped avoid further escalation of care and potential patient safety issues.
View Article and Find Full Text PDFTreating Acquired Factor VIII Inhibitor and Tumor-Induced Hypoglycemia in a Case of Relapsed Diffuse Large B-Cell Lymphoma.
J Hematol
June 2023
Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Diffuse large B-cell lymphoma (DLCBL) is a heterogenous disease, with many phenotypic subtypes and occasional paraneoplastic syndromes being present. Herein, we describe a case of a 63-year-old woman, with relapsed/refractory DLBCL (RR-DLBCL) with artifactual hypoglycemia on laboratory testing, likely related to the mechanical effects of a new factor VIII inhibitor. We demonstrate our workup, consideration, treatment, and her clinical course.
View Article and Find Full Text PDFArtifactual hypoglycaemia may be common in patients with soft tissue sarcoma who received pegfilgrastim-supported chemotherapy.
J Orthop Sci
July 2024
Department of Orthopedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu City, Mie 514-8507, Japan.
Background: Recently, we identified artifactual hypoglycemia in patients with soft tissue sarcoma (STS) who received pegfilgrastim-supported chemotherapy. In the present study, we measured white blood cell count and fasting blood glucose levels after the administration of pegfilgrastim in patients with STS and showed the relationship between artifactual hypoglycemia and white blood cell count.
Patients: A total of 19 patients were included in this study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!